Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

NCT07484971 is registered in ClinicalTrials.gov with Société Algérienne de Formation et Recherche en Oncologie as lead sponsor.

NCT NCT07484971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07484971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
Lead sponsor
Société Algérienne de Formation et Recherche en Oncologie
Phase
Observational
Overall status
Recruiting
Start date
July 21, 2025
Completion date
July 21, 2026
Enrollment
2,000 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer (adenocarcinoma), prostate cancer (diagnosis), prostate cancer (post prostatectomy), prostate cancer metastatic, prostate cancer patients treated by radiotherapy